Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 51, Issue 6 (Jun 2013)

Issues

A multiplex assay to rapidly exclude HLA-DQ2.5 and HLA-DQ8 expression in patients at risk for celiac disease

Ellen M. van Beek
  • Corresponding author
  • Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Elianne A. Roelandse-Koop
  • Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Raymon Vijzelaar / Rizkat Yilmaz / Ingrid M.W. van Hoogstraten / Marco W.J. Schreurs / Alice A.M. Verheul
  • Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Arend Jan van Houte
  • Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Department of Medical Microbiology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Wouter Kortlandt
  • Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis, Utrecht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-12-25 | DOI: https://doi.org/10.1515/cclm-2012-0774

Abstract

Background: Celiac disease (CD) is an inflammatory disorder of the small intestine induced by gluten ingestion. CD has a strong genetic association with human leukocyte antigen (HLA)-DQ2.5 and HLA-DQ8. The absence of HLA-DQ2.5 and HLA-DQ8 has a strong negative predictive value for CD. Genetic screening of HLA-DQ2.5 and HLA-DQ8 in patients at risk is of great value.

Methods: We designed, developed, and validated a multiplex assay based on multiplex ligation-dependent probe amplification (MLPA) technology, allowing the simultaneous detection of DQA1*05-DQB1*02, encoding HLA-DQ2.5, and DQA1*03-DQB1*03:02, encoding HLA-DQ8. The amplified products were separated and identified using capillary electrophoresis.

Results: When compared with a polymerase chain reaction followed by single-strand conformation polymorphism/ heteroduplex analysis, one discrepancy was found. Sequencing analysis showed that the developed MLPA assay result was correct. Furthermore, we demonstrated that the MLPA method is able to distinguish between the heterozygote and homozygote expression of HLA-DQ2.5 or HLA-DQ8.

Conclusions: This study shows that it is possible to rapidly and accurately screen for the absence of HLA-DQ2.5 and HLA-DQ8 using MLPA, excluding patients at risk for CD for further serological or histological follow-up. In addition, MLPA might be an accurate tool to screen for other specific HLA types in the context of disease association in a diagnostic laboratory setting.

This article offers supplementary material which is provided at the end of the article.

Keywords: celiac disease; DQ2.5; DQ8; human leukocyte antigen (HLA); multiplex ligation-dependent probe amplification (MLPA)

References

  • 1.

    Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286–92.Google Scholar

  • 2.

    Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003;348:2517–24.Google Scholar

  • 3.

    Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180–8.Google Scholar

  • 4.

    Chapman BL, Henry K, Paice F, Coghill NF, Stewart JS. Measuring the response of the jejunal mucosa in adult coeliac disease to treatment with a gluten-free diet. Gut 1974;15:870–4.CrossrefPubMedGoogle Scholar

  • 5.

    Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105:910–22.Google Scholar

  • 6.

    Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469–77.PubMedCrossrefGoogle Scholar

  • 7.

    Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002;2:647–55.CrossrefPubMedGoogle Scholar

  • 8.

    Margaritte-Jeannin P, Babron MC, Bourgey M, Louka AS, Clot F, Percopo S, et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004;63:562–7.Google Scholar

  • 9.

    Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713–7.PubMedCrossrefGoogle Scholar

  • 10.

    van de WY, Kooy Y, van VP, Pena S, Mearin L, Papadopoulos G, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585–8.Google Scholar

  • 11.

    Trynka G, Wijmenga C, van Heel DA. A genetic perspective on coeliac disease. Trends Mol Med 2010;16:537–50.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 12.

    Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010;7:204–13.PubMedCrossrefGoogle Scholar

  • 13.

    Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005;3: 843–51.CrossrefPubMedGoogle Scholar

  • 14.

    Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the Diagnosis of Coeliac Disease. J Pediatr Gastroenterol Nutr 2012;54:136–60.Web of ScienceCrossrefGoogle Scholar

  • 15.

    Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:1–19.CrossrefGoogle Scholar

  • 16.

    NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements 2004;21:1–23.Google Scholar

  • 17.

    Nieuwenhuis WP, Kneepkens CM, Houwen RH, de Beer HJ, Mulder CJ, Mearin ML. Guideline ‘coeliac disease and dermatitis herpetiformis’. Ned Tydschr Geneesk 2010;154:A1904.Google Scholar

  • 18.

    Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.CrossrefPubMedGoogle Scholar

  • 19.

    Csizmadia CG, Mearin ML, Oren A, Kromhout A, Crusius JB, von Blomberg BM, et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr 2000;137:756–61.Google Scholar

  • 20.

    Reinton N, Helgheim A, Shegarfi H, Moghaddam A. A one-step real-time PCR assay for detection of DQA1*05, DQB1*02 and DQB1*0302 to aid diagnosis of celiac disease. J Immunol Methods 2006;316:125–32.Web of ScienceGoogle Scholar

  • 21.

    Wouters J, Weijerman ME, van Furth AM, Schreurs MW, Crusius JB, von Blomberg BM, et al. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J Pediatr 2009;154:239–42.Web of ScienceGoogle Scholar

  • 22.

    Van Belzen MJ, Meijer JW, Sandkuijl LA, Bardoel AF, Mulder CJ, Pearson PL, et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 2003;125:1032–41.Google Scholar

  • 23.

    Volta U, Villanacci V. Celiac disease: diagnostic criteria in progress. Cell Mol Immunol 2011;8:96–102.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 24.

    Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003;100:12390–5.CrossrefGoogle Scholar

  • 25.

    Van Belzen MJ, Koeleman BP, Crusius JB, Meijer JW, Bardoel AF, Pearson PL, et al. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun 2004;5:215–20.CrossrefPubMedGoogle Scholar

  • 26.

    Louka AS, Nilsson S, Olsson M, Talseth B, Lie BA, Ek J, et al. HLA in coeliac disease families: a novel test of risk modification by the ‘other’ haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002;60:147–54.PubMedCrossrefGoogle Scholar

  • 27.

    Bodd M, Kim CY, Lundin KE, Sollid LM. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide- MHC stability in celiac disease. Gastroenterology 2012;142: 552–61.Google Scholar

  • 28.

    Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, Sollid LM. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol 2009;10:1096–101.PubMedCrossrefWeb of ScienceGoogle Scholar

About the article

Corresponding author: Ellen M. van Beek, Department of Clinical Chemistry, Hematology and Immunology, Diakonessenhuis Utrecht, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands


Received: 2012-09-27

Accepted: 2012-11-17

Published Online: 2012-12-25

Published in Print: 2013-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2012-0774.

Export Citation

©2013 by Walter de Gruyter Berlin Boston. Copyright Clearance Center

Supplementary Article Materials

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Raymon Vijzelaar, Ellen van der Zwan, Adriaan van Gammeren, Rizkat Yilmaz, Alice Verheul, Ingrid van Hoogstraten, Ellen de Baar, Lianne Schrauwen, and Wouter Kortlandt
Genetic Testing and Molecular Biomarkers, 2016, Volume 20, Number 3, Page 158
[2]
Vilte E. Barakauskas, Grace Y. Lam, and Mathew P. Estey
Critical Reviews in Clinical Laboratory Sciences, 2014, Volume 51, Number 6, Page 358

Comments (0)

Please log in or register to comment.
Log in